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CD1d Endosomal Trafficking Is Independently
Regulated by an Intrinsic CD1d-Encoded
Tyrosine Motif and by the Invariant Chain
lysosomal compartments. CD1a is present in early and
recycling endosomes (Sugita et al., 1999), while CD1b
and CD1d predominate in late endosomes and lyso-
somes (Chiu et al., 1999; Sugita et al., 1996) and CD1c
is found in early and late endosomes (Briken et al., 2000).
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are loaded in endosomal compartments (reviewed inIsrael
Park and Bendelac, 2000; Porcelli and Modlin, 1999).
For CD1d, there exists a striking dichotomy between
subsets of CD1d autoreactive NKT cells using differentSummary
TCR families. V14-J18/V8 NKT cells, a prominent
NKT subset, depend on an intact tyrosine motif for CD1dEndosomal trafficking is an essential component of the
CD1 pathway of lipid antigen presentation to T cells. autorecognition whereas V3.2-J9/V8 and V8/V8
NKT cells do not, suggesting the existence of two differ-We demonstrate that CD1d access to endosomal com-
partments is under dual regulation by an intrinsic tyro- ent pathways for CD1d acquisition of antigen (Chiu et
al., 1999; Park et al., 2001).sine-based motif, which governs intense recycling be-
tween the plasma membrane and the endosome, and Although the steady-state localization of CD1 proteins
has been well studied, a dynamic picture of traffickingby the invariant chain, with which CD1d associates in
the endoplasmic reticulum. Both pathways indepen- has not yet emerged. CD1b can associate with the mo-
lecular chaperones calnexin and calreticulin in the ERdently enhance antigen presentation to V14 NKT
cells, the main subset of CD1d-restricted T cells. before binding 2m (Huttinger et al., 1999; Sugita et al.,
1997), but little is known about trafficking after exit fromThese results reveal the complexity of CD1d trafficking
and suggest that the invariant chain was a component the ER except that CD1 proteins can be internalized
from the cell surface into endosomal compartmentsof ancestral antigen presentation pathways prior to
the evolution of MHC and CD1. (Rodionov et al., 1999; Sugita et al., 1996). In addition,
an important issue raised by the endosomal functions
of CD1 is that, in the absence of protection of the groove,Introduction
self-lipids bound prior to endosomal access could pre-
empt effective loading of endosomal lipids. A detailedMHC and CD1 diverged several hundred million years
ago from the duplication of an ancestor locus (Kasahara, study of the intracellular trafficking of CD1d and a search
for candidate CD1d-associated proteins are therefore1997). CD1 encodes proteins that associate with -2-
microglobulin (2m) and segregate, based on sequence crucial to understanding how CD1d acquires antigen in
different intracellular compartments.homologies, into a group 1, comprising CD1 a, b, c, and
e and group 2, comprising CD1d (Calabi et al., 1989). In this paper, we describe two different pathways of
CD1d trafficking to endosomal compartments that areUnlike MHC, CD1 molecules are nonpolymorphic and
present glycolipids rather than peptides to T cells (re- independently regulated by the intrinsic CD1d-encoded
tyrosine motif and by the unexpected association ofviewed in Porcelli and Modlin, 1999). Current models
suggest that the hydrophobic tails of lipid antigens bind CD1d with the invariant chain (Ii). Both pathways en-
hance antigen presentation to V14NKT cells, the maininto the groove of CD1 via hydrophobic interactions,
while the polar head groups contact the T cell receptor subset of CD1d-restricted T cells in the mouse. Our
results uncover the complexity of CD1d trafficking and(TCR) (Moody et al., 1997).
In line with the nonspecific nature of their hydrophobic suggest that, although dispensible for some aspects of
CD1d biosynthesis and trafficking, Ii retains importantinteractions, glycolipid binding by the different CD1 iso-
types seems largely promiscuous. For example, both functions in antigen presentation.
CD1b and CD1d bind similar ceramide and phophatidyli-
nositol-based lipids (reviewed in Park and Bendelac, Results
2000; Porcelli and Modlin, 1999). Thus, to explain the
conservation of individual isotypes across species, it Lifespan and Steady-State Localization
has been suggested that, rather than narrowly recogniz- We studied the intracellular trafficking of CD1d in various
ing different sets of lipids, they specialize in surveying cell types that do or do not naturally express CD1d.
different intracellular compartments through intrinsic C57SV fibroblasts transfected with CD1d may lack much
tail-encoded tyrosine-based sorting motifs. Indeed, CD1 of the machinery needed for antigen presentation and
isotypes differ in their steady-state intracellular distribu- could therefore be used to determine its minimal require-
tion, spanning the early/recycling to late endosomal/ ments. In this cell line, CD1d could be expressed on the
cell surface and present self-antigens to CD1d-restricted
T cells (Chiu et al., 1999). In contrast with fibroblasts, B3 Correspondence: abendelac@molbio.princeton.edu
4These authors contributed equally to this work. cells prominently express CD1d. We used A20, a B cell
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Figure 1. Steady-State Localization and Cell
Surface Arrival Kinetics of CD1d
Left panels: C57SV fibroblasts transfected
with CD1d. Right panels: A20 B cells trans-
fected with CD1d.
(A) Lifespan of CD1d. Pulse-labeled CD1d
proteins were chased for indicated periods
of time before immunoprecipitation.
(B) Steady-state localization of CD1d. Note
the extensive colocalization (in yellow) be-
tween CD1d (red) and LAMP-1 (green).
(C) Surface arrival of CD1d. Cells were pulse
labeled and chased as in (A), surface biotinyl-
ated, and immunoprecipitated with anti-
CD1d, anti-Kb, or anti-Kd. A portion of the im-
munoprecipitate was adsorbed against
streptavidin agarose beads and designated
“Surface,” and the remainder of the immuno-
precipitate was run as an indicator of “Total”
labeled protein. Molecular weight markers (in
kilodaltons) are indicated on the left of each
gel.
line that naturally expresses little CD1d, for transfection. previous observations in A20 cells (Thery et al., 1998).
Thus, it appears that in both professional and nonprofes-In both fibroblasts and B cells, the half-life of CD1d was
greater than 15 hr, compared with 3 hr for MHC class I sional CD1d-expressing APC, a cohort of CD1d mole-
cules reaches the cell surface quickly after synthesis.(Figure 1A and data not shown). In both cell types, CD1d
was heavily glycosylated, although the transition to the These results would be consistent with a direct route
to the cell surface after exiting the trans-Golgi networkfully glycosylated protein lasted longer in B cells (Figure
1A). The steady-state distribution of the CD1d protein was (TGN) as well as with a transient stop in endosomes on
the way to the cell surface.apparently similar in both cell lines, with a large pool of
intracellular CD1d protein colocalizing with LAMP-1 (Fig-
ure 1B). In A20, CD1d only partially colocalized with the Surface Internalization and Recycling
Using biotin-based endocytosis assays as well as confo-MHC class II molecule I-Ad (Figure 1B and data not shown)
consistent with the preferential distribution of I-Ad to early cal imaging after surface labeling with Fab antibodies,
we determined the rate of internalization and recycling,endosomes in this cell line (Pierre et al., 1996).
the size of the recycling pool, and the final destination
of internalized CD1d.Cell Surface Arrival of Newly Synthesized Proteins
Next, we compared the cell surface arrival kinetics of Internalization of the wild-type CD1d protein (CD1-WT)
was compared to a protein in which the tyrosine-basednewly synthesized CD1d with that of MHC class I, which
is known to travel quickly to the cell surface after synthe- motif was deleted (CD1-TD). In both C57SV fibroblasts
and Rat Basophil Leukemia cells (RBL) transfected withsis. In fibroblasts, CD1d was detected at the cell surface
within 30 min after synthesis, similar to H-2Kb (Figure CD1-WT or CD1-TD, the rate of internalization of CD1-WT
was significantly greater than that of CD1-TD (Figure 2A1C). In B cells, it took 1 hr for CD1d to reach the cell
surface, but this slight delay could be due to the slower and data not shown).
Recycling of internalized, surface-biotinylated CD1dprocessing of CD1d in the Golgi. As soon as the higher
MW form of CD1d was detected, CD1d could be seen molecules was measured by comparing the loss of sig-
nal after a second round of stripping to that of a non-on the cell surface, indicating quick transport of the fully
processed protein to the cell surface. H-2Kd in A20 cells stripped control (Turvy and Blum, 1998). Figure 2B
shows that both CD1-WT and CD1-TD recycled at areached the cell surface 1 hr after synthesis (Figure 1C).
I-Ad could be detected on the cell surface within 1 hr similar rate. Rates of surface internalization were esti-
mated at 1.5% per min for CD1-WT and 0.6% for CD1-TD,after synthesis as well (data not shown), consistent with
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Figure 2. Surface Internalization and Recycling of CD1d
(A) Internalization of CD1-WT and CD1-TD proteins expressed by C57SV transfectants was measured using a biotin-based endocytosis assay.
Results are a summary of seven independent experiments with triplicate samples for each experiment.
(B) Recycling of internalized, biotinylated CD1-WT, and CD1-TD proteins (see Experimental Procedures). Results are a summary of seven
independent experiments with triplicate samples for each experiment.
(C) The size and lifespan of the recycling pool of CD1d. C57SV transfectants were incubated at 4C with biotinylated Fab fragments of anti-
CD1d mAb and then shifted to 37C to allow internalization and recycling. Cells were then surface labeled with streptavidin-PE and analyzed
by flow cytometry. The mean fluorescent intensity was 575 at 0 hr, 211 at 1 hr, 195 at 3 hr, and 190 at 5 hr.
whereas recycling rates were identical at 4.5% of inter- were negative for lysosomal markers. By 3 hr, some
fully processed forms of CD1d could be detected innalized CD1 per min (see Experimental Procedures).
To determine the size of the recycling pool, we labeled lysosomal compartments, but the majority of the protein
was still in the nonlysosomal fractions. AccumulationCD1d on the plasma membrane with biotinylated Fab
antibodies at 4C. After shifting to 37C for up to 5 hr, of CD1d in lysosomes occurred gradually over 24 hr.
Together with the Fab labeling experiment, this resultwe surface stained the cells with streptavidin-PE. Figure
2C shows that half the label was rapidly lost from the establishes that a steady-state concentration of CD1d
in the LAMP-1 compartments results from the late ac-cell surface and equilibrium reached within 1 hr and
maintained for the next 4 hr. Thus, surface CD1d mole- cumulation of long-lived CD1d that has presumably un-
dergone several rounds of internalization and recyclingcules belong to a larger pool that is long lived and recy-
cles intensely between the plasma membrane and the between the plasma membrane and the endosome.
intracellular compartment.
To trace the compartments traveled after surface in- CD1d Associates with the Invariant Chain
ternalization, we labeled surface CD1d with Fab frag- Experiments designed to identify candidate molecules
ments of anti-CD1d. CD1-WT was detected in TfnR involved in CD1d trafficking and antigen presentation
early endosomes 10 min after internalization, in M6PR showed that in BCL-1, a B cell line which naturally ex-
late endosomes after 20 min, and in LAMP-1 late endo- presses CD1d, a 31 kDa protein could be coprecipitated
somal/lysosomal compartments after 20–30 min (Figure with CD1d under certain detergent conditions using
3A and data not shown). The LAMP-1 compartments CHAPS (Figure 4A). This protein was identified as being
remained fluorescent for extended periods of time (data Ii by reprecipitation with the anti-Ii antibody IN-1 (Figure
not shown) suggesting that they are a site of long-term 4B). The association of CD1d with Ii was also confirmed
storage. Similar results were obtained in the A20 B cell in the A20 B cell line transfected with CD1d (data not
line transfected with CD1-WT (data not shown). In con- shown) and in RBL cells transfected with both CD1d
trast, CD1-TD exhibited a profoundly modified pattern. and Ii (see below, Figure 4D).
It was detected in early endosomes only after 20–30 In pulse-chase experiments (Figure 4C), the associa-
min but did not significantly accumulate in LAMP-1 tion of Ii with CD1d was found during early synthesis in
compartments even after extended periods of chase the ER as well as at later time points (3 and 6 hr of
(Figure 3B and data not shown). chase), including Endoglycosidase H (Endo H)-resistant
stages. Similar results were found in RBL-CD1d/Ii, and
reprecipitation experiments (Figure 4D) confirmed theEntry into Lysosomes
To more precisely study the kinetics of trafficking to association of Endo-H resistant Ii with CD1d. Associa-
tion with the p10 fragment of Ii could not be detectedthe LAMP-1 compartment, we carried out a metabolic
pulse labeling of CD1d in A20 B cells, followed by a at any time point, perhaps because its association with
CD1d is too transient or weak to be evidenced in thischase for different periods of time and subcellular frac-
tionation. A 27% Percoll gradient was used to isolate assay.
This finding suggested the possibility that in APC,dense lysosomal -hexosaminidase compartments
(Castellino and Germain, 1995) and CD1d was immuno- where both CD1d and Ii are expressed, Ii could associate
with at least a fraction of CD1d molecules and regulateprecipitated from the different fractions. After 1 hr of
chase, all labeled CD1d, including mature glycosylated both the targeting to endosomal compartments and an-
tigen presentation. Ii has been shown to interact withand immature forms (upper and lower bands, respec-
tively), was present in lower density fractions, which MHC class II and H2-M (Blum and Cresswell, 1988;
Immunity
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Figure 3. Surface Internalization and Gradual
Accumulation of CD1d in Late Endosomes
and Lysosomes
Surface CD1d was labeled with Fab anti-
CD1d and internalization for CD1-WT (A) and
CD1-TD (B) in transfected C57SV cells was
followed using confocal microscopy with the
indicated endosomal markers. CD1d is in red,
transferrin receptor and LAMP-1 in green.
(C) Subcellular fractionation shows delayed
accumulation of pulse-labeled CD1d in the
dense lysosomes of A20 cells.
Castellino and Germain, 1995; Lindstedt et al., 1995; association of CD1d and Ii seemed rather weak in the
cell lysate immunoprecipitation assay, its physiologicalLotteau et al., 1990), delivering these proteins to endoso-
mal or lysosomal compartments. However, because the significance remained to be tested.
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Figure 4. CD1d Associates with Ii in the ER
(A) Association of a 31 kDa protein with CD1d. BCL-1 cells were metabolically labeled for 2 hr followed by lysis of the cells in 0.5% Triton-
X100, 1% Digitonin, or 0.3% CHAPS. Immunoprecipitation of anti-CD1d in 0.3% CHAPS lysis conditions shows a 31 kDa protein. Arrows on
the right indicate the position of 2m, the 31 kDa protein, and the mature (upper) and immature (lower) forms of CD1d.
(B) The 31 kDa protein is reimmunoprecipitated by the IN-1 anti-Ii antibody. Anti-CD1d immunoprecipitate was reimmunoprecipitated with
anti-CD1d or anti-Ii.
(C) Kinetics of CD1d association with Ii. BCL-1 cells were pulsed labeled and chased for 0–6 hr. CD1d was immunoprecipitated and either
treated with Endo-H or left untreated as indicated. Endo-H-resistant (Endo-HR) or sensitive (Endo-HS) forms of Ii and CD1d are indicated by
arrows on the right. Apparent molecular weights (in kilodaltons) are displayed on the left of each gel.
(D) Endo-H-resistant Ii is reimmunoprecipitated from CD1d immunoprecipitates in RBL-CD1d/Ii tranfectants.
Ii Redistributes CD1-TD into Endosomes dextran uptake into endosomal compartments and
found it to be unaffected by Ii expression (Figure 5C).Since CD1d is already present in endosomes at the
steady state due to its own tyrosine-based sorting motif, These results indicate that the transfected Ii did not
detectably modify the endocytic pathway, in support ofwe could not determine whether Ii exerts its endosomal
sorting function on intact CD1d. Instead, we took advan- the specificity of the Ii effect on CD1d.
tage of the CD1-TD mutant protein, which at steady
state is mostly present on the cell surface of RBL cells Ii-Deficient B Cells and Dendritic Cells Redistribute
CD1d to the Cell Surfacewith little endosomal localization. Transfection of RBL
cells expressing CD1-TD with Ii resulted in a redistribu- To study the effect of Ii on CD1-WT, we examined Ii-
deficient mice, reasoning that if Ii deviates CD1d to thetion of CD1-TD from the cell surface into an intracellular
compartment that largely overlapped with the LAMP-1 endosome, the steady-state levels of surface CD1d
might be increased in the absence of Ii. Indeed, welate endosome/lysosome containing Ii (Figure 5A). This
result suggests that the association of CD1d with Ii is found a 50%–100% increased level of cell surface CD1d
expression in Ii-deficient over Ii-sufficient cells (Figurefunctional and results in transport of CD1d into endo-
somes. To address the possibility that overexpression 5D). Importantly, only cells that naturally express Ii, such
as B cells and dendritic cells, exhibited this increase,of Ii primarily altered the endosomal compartments, as
reported by Gorvel et al. (1995) and Romagnoli et al. whereas cortical thymocytes, which do not express the
Ii, did not show altered levels. In addition, control surface(1993), resulting in nonspecific redistribution of surface
CD1-TD into the LAMP-1 compartment, we performed proteins such as the transferrin receptor and MHC class
I were unaffected, confirming the specificity of the Iiseveral control experiments. First, we quantified the Ii
content using intracellular FACS staining with IN-1. As effect (data not shown). It is noteworthy that Ii/- cells
did not exhibit changes in CD1d expression, confirmingshown in Figure 5B, in all the cell lines examined, includ-
ing RBL-CD1-TD/Ii, the Ii content was 2- to 5-fold lower that low levels of Ii are sufficient to regulate CD1d. In
addition, neither MHC II-deficient mice (Figure 5D) northan in fresh B cells or dendritic cells. Next, we stained
the transferrin receptor and the MHC class I molecule H2-M-deficient mice (data not shown) exhibited changes
in CD1d, excluding indirect effects of Ii. We concludeexpressed by RBL cells and found that Ii expression did
not redistribute these proteins to the LAMP-1 compart- that, by sequestering CD1d in the endosome, Ii specifi-
cally decreases surface CD1d, strongly supporting thement (Figure 5C). Finally, we measured the kinetics of
Immunity
902
Figure 5. Ii Redirects CD1-TD to the Endosome
(A) Localization of CD1d and Ii (upper panels) or LAMP-1 (lower panels) in RBL cells expressing either CD1-TD alone (left panels) or CD1-TD
and Ii (right panels). In the absence of Ii, CD1-TD is mostly present on the cell surface with little colocalization with LAMP-1. In the presence
of Ii, increased intracellular CD1-TD partially colocalizes with Ii and with LAMP-1.
(B) Intracellular levels of Ii in cell lines and fresh cells. The dark line indicates specific Ii staining, and the faint line is the staining control. Peak
values of fluorescence measured by intracellular flow cytometry are indicated with arrows.
(C) Unaltered endocytic functions in Ii transfectants. The steady-state localization of rat MHC class I and transferrin receptor (in green) do
not overlap with LAMP-1 (in red) in the presence or absence of Ii in RBL-CD1-TD cells (left four panels). The uptake of fluorescent dextran is
unaltered in the presence of Ii (right four panels).
(D) Increased surface levels of CD1d in APC of Ii-deficient mice. FACS profiles of thymocytes, B cells, or DCs are shown for Ii cells (including
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notion that Ii regulates the intracellular trafficking of (Brutkiewicz et al., 1995; Porcelli et al., 1992). With the
exception of CD1a, CD1 molecules express intrinsic tail-CD1d in vivo.
encoded tyrosine-based motifs which, in heterologous
transfection experiments, accounted for the steady-Ii Plays a Functional Role in Antigen
state localization of CD1 isotypes spanning the early toPresentation by CD1d
late endosomes and lysosomes. In some of the exam-In order to determine whether the association of CD1d
ples of antigen presentation studied so far, recognitionwith Ii had functional consequences on antigen recogni-
by T cells required the tail motif and/or endosomal acidi-tion, we tested whether the transfection of Ii into
fication. These studies led to a model whereby antigenCD1-TD-expressing cells would restore CD1-TD autore-
loading may occur either in the secretory pathway or,cognition by V14 T cells. We used T cells from the
presumably after antigen exchange, on the cell surfaceV14 transgenic mouse, which have the same TCR 
and in different endosomal compartments betweenchain but different  chains, providing a broad poly-
which CD1 molecules recycle back and forth (Jayawar-clonal source of V14 TCRs (Bendelac et al., 1996).
dena-Wolf and Bendelac, 2001; Porcelli and Modlin,Normally, CD1d autoreactive V14 T cells respond very
1999).poorly to C57SV or RBL cells expressing CD1-TD (Chiu
To test this model, we performed a kinetic study ofet al., 1999). However, upon Ii transfection, a dose-
CD1d trafficking in various cell types, defining the se-dependent reconstitution of CD1d recognition by trans-
quential steps of surface arrival, internalization, and re-genic V14 T cells could be observed (Figure 6A). Simi-
cycling to endosome. We demonstrate prompt surfacelar results were obtained in independent transfection
arrival and intense internalization/recycling between theexperiments and using different subclones of trans-
plasma membrane and the endosome prior to gradualfected lines (Figure 6B). We carried out the same experi-
accumulation in the lysosome. We show that the tyro-ment using the V14 T cell hybridoma DN32.D3 and
sine-based sorting motif of CD1d is required for surfacefound the same results as with transgenic V14 T cells
recycling and access to the late endosome/lysosome(data not shown). Stimulation of the non-V14 CD1d-
compartments. Because we found that the cytoplasmicautoreactive T cell hybridomas by the RBL transfectants
tail of CD1d was also sufficient to redirect an MHC classwas also studied. These non-V14 T cells were pre-
I molecule (H-2Kd) to the LAMP-1 compartment (dataviously shown to respond equally to CD1-WT and CD1-TD
not shown), the combined evidence delineates a unique,suggesting that they recognize a secretory or a ubiqui-
intrinsic pathway of CD1d trafficking that is governedtous ligand (Chiu et al., 1999). We found that, in contrast
by its tyrosine-based sorting motif.with the V14 T cells, the non-V14 T cell hybridomas
Our study also points to the surprising involvement ofrecognized the CD1-TD/Ii double transfectants as well
Ii, the same protein that governs MHC class II endosomalas the CD1-TD or CD1-WT single transfectants (Figure
access and antigen loading, in CD1d trafficking and6C). Thus, like the CD1d tyrosine motif, Ii has differential
antigen presentation.
effects on CD1d recognition, reinforcing the dichotomy
We coprecipitated Ii by immunoprecipitating CD1d in
between different families of CD1d-autoreactive TCRs.
BCL-1, a mouse B cell line that naturally expresses both
The results suggest that Ii-mediated targeting of CD1-TD CD1d and Ii. Similarly, Ii could be coprecipitated from
to the endosome has functional consequences, allowing CD1d-transfected A20 B cells and from RBL cells doubly
the loading of endosomal self-antigens in a manner simi- transfected with CD1d and Ii. RBL cells are MHC II nega-
lar to the CD1d-encoded tyrosine motif. Conversely, to tive, excluding an indirect association of CD1d with the
study the effect of Ii on intact CD1d, we compared the invariant chain through MHC II molecules. It is notewor-
ability of dendritic cells from wild-type and Ii knockout thy that, whereas the association of CD1d with Ii could
mice to present antigen to CD1d-restricted T cells (Fig- be detected in cell lysates made with 0.3% CHAPS,
ure 6D). The wild-type dendritic cells stimulated 2/2 en- neither digitonin nor Triton X-100 allowed coprecipita-
dosomal-dependent, V14-positive T cell hybridomas more tion. This is unlike the association of MHC class II with
efficiently than the Ii-deficient dendritic cells, whereas both Ii (Anderson and Cresswell, 1994). Furthermore, the
dendritic cells stimulated equally well 4/4 control, endoso- CD1d/Ii association, though present at the Endo-H-
mal-independent V14-negative hybridomas. These re- resistant stages, was weaker than at the Endo-H-sensi-
sults indicate that Ii plays a substantial role in endosomal tive stage, and the proteolytic fragment p10 was not
antigen presentation even in the presence of an intact coprecipitated at later time points. These limitations of
CD1d tail in vivo. the biochemical analysis may reflect instability of the
CD1d/Ii complexes in detergent lysates, precluding a
Discussion formal characterization of the binding in different cellular
compartments. Alternatively, since CD1d is stable in the
Despite their restricted pattern of tissue expression in absence of Ii, only a fraction of CD1d molecules might
vivo, CD1 isotypes can be stably expressed and func- associate with Ii. Nonetheless, several experiments
tional in various heterologous transfected lines, seem- strongly support the notion that the association of CD1d
ingly independent of known accessory molecules of the with Ii is physiologically relevant and has substantial
functional consequences.MHC class I and II pathways, such as TAP, Ii, and H2-M
wild-type (WT), MHC class II deficient (class II /), and Ii heterozygous (Ii /) and for Ii  cells (Ii /). The average  standard deviation
of the mean fluorescent intensities is summarized below representative flow cytometry profiles. The number of mice in each group were WT,
n  50; class II /, n  25; Ii /, n  10; Ii /, n  50.
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Figure 6. Ii Restores the Stimulation of V14 T Cells by CD1-TD in a Dose-Dependent Manner
(A) Stable RBL transfectants expressing indicated levels of CD1-WT or CD1-TD and Ii were used to stimulate IL-4 production by Con-A blasts
derived from V14-transgenic thymocytes (Chiu et al., 1999).
(B) Summary of five independent experiments as described in (A).
(C) Stable RBL transfectants stimulate the CD1d-autoreactive non-V14 T hybridomas S2M15 and TCB11 independently of the CD1d tail
motif or Ii.
(D) Ii-deficient dendritic cells exhibit impaired stimulation of V14pos (DN32.D3 and TB.H1) but not V14neg (TB.A7, TCB11, TB.D7 and 1C8.DC1)
CD1d-autoreactive hybridomas. Background IL-2 production is determined in the presence of CD1d/ dendritic cells.
First, targeting-deficient CD1-TD molecules were re- and dendritic cells from Ii-deficient mice suggested a
function of Ii in surface expression and antigen presenta-directed to endosomal compartments by cotransfection
of Ii. Further, upon expression of Ii, the CD1-TD transfec- tion by wild-type CD1d. Thus, consistent with the notion
that Ii deviates CD1d to the endosome for antigen load-tants recovered the ability to stimulate V14 NKT cells.
The ability of Ii to substitute for the CD1d tail was dose ing, Ii-deficient APC (i) had higher surface CD1d expres-
sion (ii) yet were deficient in their ability to stimulatedependent, occurring at levels that were well within the
physiological range determined by intracellular flow cy- V14 T cells.
Thus, we conclude that physiological levels of Ii regu-tometry analysis of fresh B cells and dendritic cells.
Second, examination of fresh antigen-presenting B cells late CD1d trafficking and antigen presentation both in
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vitro in transfected cell lines and in vivo in normal anti-
gen-presenting cells.
The detailed trafficking of CD1d/Ii complexes and their
point of entry in the endocytic pathway remain to be eluci-
dated. We did not detect an early arrival of CD1d to the
Percoll-purified dense lysosome in the presence of Ii. This
would imply that CD1d/Ii complexes arrive to endosomal
compartments that are distinct from the dense lysosome,
though they partially overlap with the LAMP-1compart-
ment. Further, an examination of the kinetics of surface
arrival of CD1-TD in RBL transfectants failed to detect
a significant delay when Ii was expressed (data not shown).
This could be consistent with either CD1d/Ii complexes
reaching the cell surface first or transiting rapidly
through the endosome en route to the cell surface. Al-
though these results seem to contrast with those found
for MHC class II, they are not unprecedented, as others
for example have documented that, in A20 cells, I-Ad
molecules promptly reached the cell surface and did
Figure 7. Two Pathways for Endosomal Access by CD1dnot localize to the dense lysosome (Brachet et al., 1997;
(A) Intrinsic pathway: in cells without Ii, CD1d reaches the cell sur-Pierre et al., 1996; Thery et al., 1998).
face through the secretory pathway, presumably loaded with endog-Altogether, these experiments indicate that, although
enous lipids, and recycles extensively between the plasma mem-both the endosomal targeting motif in the cytoplasmic
brane and endosomes, gradually accumulating in lysosomes.
tail of CD1d and the association of CD1d with Ii indepen- (B) Extrinsic pathway: in the presence of Ii, a fraction of CD1d mole-
dently enhance endosomal trafficking and antigen pre- cules could be rapidly targeted to the endosomes where, after pro-
sentation, these two pathways are neither identical nor teolytic cleavage of Ii, they would be free to load antigens and travel
to the cell surface.redundant. For example, the CD1d cytoplasmic tail
strictly controls the extensive recycling between the
plasma membrane and the endosome and the gradual changes in trafficking and antigen sampling associated
accumulation in the lysosome. The association of CD1d with Ii.
with Ii opens the possibility that the CD1d groove might In conclusion, this study delineated a unique pathway
be protected until arrival in the endosome, enhancing its of CD1 trafficking and antigen presentation and demon-
ability to sample endosomal antigens. Based on these strated a new, unexpected function of Ii. As there is
observations, we propose that CD1d trafficking and anti- evidence that the MHC and CD1 genes arose early in
gen presentation are under the dual control of indepen- vertebrate evolution after the duplication of a primordial
dent mechanisms of endosomal trafficking, providing a locus (Kasahara, 1997), our data suggest that Ii was
more flexible system that could be regulated in multiple already an essential component of the cellular functions
ways in different cell types (Figure 7). For example, alter- associated with their common ancestor. In diverging
ations in the level of the adaptor proteins or modification away from MHC class II, most MHC class I molecules—
of the tyrosine motif would impact the intrinsic recycling though perhaps not all (Sugita and Brenner, 1995)—lost
pathway (Fingerhut et al., 2001; Garrett et al., 2000; the ability to bind Ii. Future studies will reveal whether
Marks et al., 1996; Shiratori et al., 1997), whereas the the other CD1 isotypes found in nonrodent species have
extrinsic Ii pathway could be regulated by transcriptional remained under the regulation of Ii.
control or proteolysis of the invariant chain (Pierre and
Experimental ProceduresMellman, 1998). It is also possible that, as shown for
MHC class II (Zhong et al., 1997), the recycling pathway
CD1d and Ii Transfectantsand the Ii pathway would expose CD1d to different sets
The mouse fibroblast cell line C57SV (Knowles et al., 1979), the ratof antigens.
basophil leukemia RBL (Kulczycki et al., 1974), and the IIA1.6 variant
One area in which the two pathways could take on of the A20 murine B lymphoma cell line that has lost Fc receptor
different functions is in the thymic selection of CD1d- expression (Jones et al., 1986) were transfected. Electroporation
restricted T cells in comparison with their peripheral was carried out using 10–50 g of linearized mouse CD1d (Park et
al., 1998) or Ii vector (Bonnerot et al., 1994). Stable transfectantsactivation. The positive selection of V14 NKT cells is
were selected by either G418, or G418 plus zeocin treatment fordependent on bone marrow-derived rather than epithe-
single and double transfectants, respectively, and subcloned to se-lial elements of the thymus and is thought to require
lect for cells with similar levels of CD1d and varying levels of Ii.
cortical thymocytes (Bendelac, 1995; Coles and Raulet,
2000) which, unlike B cells or DC, do not express Ii. T Cell Hybridomas
Another intriguing aspect of CD1d-mediated antigen The T cell hybridomas used were the V14 hybridomas DN32.D3
(Lantz and Bendelac, 1994) and TB.H1 (Park et al., 1998); the V8presentation is a certain degree of tissue specificity in
hybridomas TCB11 and TB.A7 (Chiu et al., 1999); the V3 hybrid-CD1d self-recognition by some autoreactive T cells (Bros-
oma S2M15 (Park et al., 2001); and the non-V14 hybridomassay et al., 1998; Park et al., 1998). For example, some
TB.D7 (Park et al., 1998) and 1C8.DC1 (Chiu et al., 1999).T cells respond better to CD1d expressed by B cells than
by cortical thymocytes, whereas conversely, others re- Antibodies
spond better to CD1d expressed by cortical thymocytes Antibodies used were rat anti-mouse CD1d 20H2 and 19G11 (Roark
et al., 1998), rat anti-mouse IAb antibody M5/114 (PharMingen, Santhan by B cells. This could be related in part to the
Immunity
906
Diego, CA ), rat anti-mouse Kb R1.21.2 (Bendelac, 1995), rat anti- Immunoprecipitation of Invariant Chain with CD1d
BCL-1 cells (Slavin and Strober, 1978), a B cell line which naturallymouse Kd 34-5-8S, mouse anti-rat LAMP-1 Ly1C6, rat anti-mouse
transferrin receptor antibody C2 (PharMingen), rat anti-mouse expresses CD1d, MHC class I and II, and Ii, or RBL transfectants,
were pulse labeled with 35S-cysteine/methionine for 20 min andLAMP-1 1D4B (PharMingen), and rat anti-mouse Ii IN-1. Secondary
antibodies used for immunofluorescence were Alexa Fluor-conju- chased for different times after which cells were lysed in 0.3% CHAPS
(Sigma) and immunoprecipitated with 19G11 (anti-CD1d). For reimmu-gated goat anti-mouse IgG, goat anti-rabbit IgG, and goat anti-rat
IgG (Molecular Probes). Fab fragments of the rat anti-mouse CD1d noprecipitation of Ii, immunoadsorbed proteins were eluted from
beads by boiling the samples for 5 min in 100 l of 0.5% SDS. The20H2 antibody were made using the ImmunoPure Fab Preparation
Kit (Pierce) according to manufacturers instructions, followed by eluted material was diluted in 900 l of lysis buffer containing 0.3%
CHAPS and reimmunoprecipitated with Protein G beads coupled tocentrifugation through Centricon YM-100 columns (Millipore). The
Fab preparation contained less than 5% undigested or partially specific antibodies (19G11 for CD1d, or IN1 for Ii).
digested material, and we verified that at the dilution used, this
undigested material would not contribute to the antibody staining. Deglycosylation
Immunoadsorbed proteins were treated with Endoglycosidase H
(Endo H) for 18 hr at 37C according to the manufacturer’s instruc-Steady-State Immunofluorescence for Adherent Cell Lines
tions (Roche).Cells were grown on coverslips and fixed with 3% paraformaldehyde
(Fisher) for 15 min, quenched with 100 mM glycine in PBS for 10
Biotin-Based Internalization Assaymin, and permeabilized with PBS/BSA/saponin (PBS plus 0.2% BSA
A cleavable biotin reagent, Sulfo-NHS-S-S-Biotin (Pierce) wasand 0.05% saponin) for 20 min. Antibodies, diluted in PBS/BSA/
added to 30 million cells (0.5 mg/ml in HBSS at 4C for 15 min)saponin, were added onto the coverslips and incubated for 30 min.
followed by washing with cold HBSS plus 5 mM Tris (pH 7.4) toCoverslips were mounted on slides with Mowiol (Calbiochem) and
quench any excess biotin reagent. Biotinylated cells were incubatedexamined by confocal microscopy with a BioRad MRC600 machine.
at 37C to allow internalization of cell surface proteins. Biotinylated
proteins remaining on the cell surface were stripped of their biotin
Immunofluorescence Antibody Internalization Assay
in a glutathione solution (0.05 mM glutathione, 0.075 mM NaCl, 0.001
Cells were grown on coverslips after which biotinylated anti-CD1d
mM EDTA, 0.075 mM NaOH, and 10% FCS) by rocking for 20 min
Fab in RPMI without FCS was added for 30 min on ice. The coverslips
at 4C followed by pelleting and resuspension in fresh, cold glutathi-
were washed in PBS, resuspended in prewarmed RPMI plus 10%
one for 30 min at 4C. Cells were washed three times with HBSS
FCS and placed at 37C for different lengths of time before washing
prior to lysis in 1% Triton X-100. In order to determine the kinetics
with ice-cold PBS. The following steps were then carried out on ice.
of recycling of endocytosed proteins back to the cell surface, cells
Cells were fixed with 3% paraformaldehyde (Fisher) for 15 min,
were allowed to endocytose proteins for 20 min at 37C. Glutathione
quenched with glycine for 10 min, and permeabilized with PBS plus
stripping was carried out and cells were shifted back to 37C for
0.2% BSA and 0.05% saponin for 20 min. Antibodies for early endo-
different lengths of time to allow internalized proteins to recycle
somes (transferrin receptor), or late endosomes/lysosomes (LAMP-1)
back to the cell surface. A second round of glutathione stripping
were diluted in PBS/BSA/saponin, added onto the coverslips, and
was carried out. The amount of recycled proteins was calculated
incubated for 30 min. Coverslips were washed and mounted on
by comparing the loss of biotin after the second round of stripping
slides with Mowiol for confocal microscopy. For the dextran uptake
with a nonstripped control. In order to determine the amount of
experiments, RBL cells transfected with CD1-TD, or CD1-TD and Ii,
biotinylated CD1 proteins present in the different samples, lysates
were cultured on coverslips for 2 hr at 37C. Texas-Red coupled to
were subjected to a capture ELISA.
40,000 MW dextran (Molecular Probes) was added at a concentra-
tion of 1 mg/ml for 1 or 2 hr. Cells were washed extensively with
Estimates of Rates of Recycling and InternalizationPBS before fixation, permeabilization, and staining of LAMP-1.
To calculate the rates of recycling and internalization, we assumed
a simple model such that CD1d molecules can be either in one of
Flow Cytometry-Based Antibody Internalization Assay two compartments, the cell surface or “outer” compartment (Co)
Cells were incubated with biotinylated Fab fragments of 20H2 anti- and the “internal” (Ci) compartment. We assumed that both internal-
CD1d mAb for 30 min on ice and then shifted to 37C for different ization and recycling proceed at constant rates, denoted by ri and
lengths of time to allow internalization. The cells were then surface rr, respectively, and that at least in the first few minutes, we may
labeled with streptavidin-PE (PharMingen) and analyzed by flow neglect internalization. We are left only with recycling at a constant
cytometry using a FACScan (Becton Dickinson) and CellQuest soft- rate, which means an exponential decay of Ci from the initial value
ware (Becton Dickinson). Ci(0). We plotted the behavior of the recycling-only model for various
values of rr superimposed on the experimental data for up to 40 min
of recycling and determined rr to be similar for both CD1-WT andPulse-Chase Labeling, Cell Surface Biotinylation,
CD1-TD with a value of 4.5%  0.5% internalized protein recyclingand Immunoprecipitation
per minute. Next, we used the full model, which includes both internal-Cells were metabolically labeled for 20 min with 35S cysteine/methio-
ization and recycling, with the rate of recycling set at 4.5% per minute.nine (0.5 mCi/ml; Amersham-Pharmacia Biotech), chased for various
We plotted the behavior of the full model for various values of riperiods of time at 37C with normal culture medium supplemented
again superimposed on the experimental data for up to 90 min.with a 15-fold excess of cysteine/methionine. At the end of the
These plots showed that the most likely ranges of ri were 1.5% chase, cells were biotinylated for 2 min with NHS-biotin (2 mg/ml
0.5% per minute for CD1-WT, and 0.6%0.1% per minute for CD1-TD.in PBS at 4C; Pierce) and lysed in 1% Triton X-100 (Shelton Scien-
tific). The lysates were immunoprecipitated with antibodies against
CD1d, MHC class I, or MHC class II coupled to protein G-Sepharose Subcellular Fractionation
About 150 million cells were used for each experiment. Cells werebeads (Amersham-Pharmacia Biotech) for 3 hr at 4C. Proteins were
eluted from the beads for 5 min at 100C in 100 l of PBS-2% SDS. metabolically labeled with 35S-cysteine/methionine ProMix (Amer-
sham) for 20 min, washed in PBS, and resuspended in normal mediaTwenty microliters of the eluted sample was taken for subsequent
SDS-PAGE analysis (“total” molecules), and the remainder was incu- with 15-fold excess unlabeled cysteine/methionine and placed at
37C for different lengths of time. Cells were washed twice in PBSbated with streptavidin-agarose beads (Pierce) in 1 ml of PBS-2%
NP-40 for 2 hr at 4C to precipitate the biotinylated fraction of the and once in homogenization buffer HB (0.25 M sucrose), resus-
pended in 1 ml HB with protease inhibitors, and placed on iceimmunoprecipitated molecules (“surface” molecules). After wash-
ing, precipitated molecules were eluted from the beads in 15 l for 20 min. Homogenization was carried out using a glass Dounce
homogenizer (Wheaton, Millville, NJ) and 50 strokes. Intact cells andSDS-PAGE sample buffer at 100C for 5 min before being analyzed
on 12.5% polyacrylamide SDS gels. Quantification was conducted debris were pelleted at 1200 rpm for 5 min, the supernatant was
removed, and the pellet washed with 1 ml HB. Pooled supernatantsusing the ImageQuant software on a Molecular Dynamics Phos-
phorImager. were loaded in the middle of a 9 ml 27% Percoll (Amersham-Phar-
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macia Biotech) solution on top of a 1 ml 2.5 M sucrose cushion. Calabi, F., Jarvis, J.M., Martin, L., and Milstein, C. (1989). Two
classes of CD1 genes. Eur. J. Immunol. 19, 285–292.The tubes were centrifuged in a Beckman VTi50 rotor at 18,500 rpm
(34,500	 g) for 1 hr at 4C. Fractions were collected in 1 ml amounts Castellino, F., and Germain, R.N. (1995). Extensive trafficking of
from the bottom of the tube. Fractions were assayed for the pres- MHC class II-invariant chain complexes in the endocytic pathway
ence of -hexosaminidase, a lysosomal marker, or for alkaline phos- and appearance of peptide-loaded class II in multiple compart-
phodiesterase, a marker for plasma membranes (Storrie and Mad- ments. Immunity 2, 73–88.
den, 1990). The fractions were centrifuged at 100,000 	 g for 1 hr
Chiu, Y.H., Jayawardena, J., Weiss, A., Lee, D., Park, S.H., Dautry-
to pellet the Percoll. Protease inhibitors and 1% NP-40 were added
Varsat, A., and Bendelac, A. (1999). Distinct subsets of CD1d-restricted
to the fractions prior to immunoprecipitation with the 20H2 antibody.
T cells recognize self-antigens loaded in different cellular compart-
ments. J. Exp. Med. 189, 103–110.
Intracellular Flow Cytometry of Invariant Chain
Coles, M.C., and Raulet, D.H. (2000). NK1.1 T cells in the liver ariseCells were fixed and permeabilized using the Cytofix/Cytoperm kit
in the thymus and are selected by interactions with class I molecules(PharMingen). Permeabilized cells were incubated with IN-1 primary
on CD4CD8 cells. J. Immunol. 164, 2412–2418.antibody in Perm/Wash buffer (PharMingen) followed by PE-conju-
Fingerhut, A., von Figura, K., and Honing, S. (2001). Binding of AP2gated mouse anti-rat kappa secondary antibody in Perm/Wash
to sorting signals is modulated by AP2 phosphorylation. J. Biol.buffer.
Chem. 276, 5476–5482.
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